Supplementary Table 6 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between fibroids and triple negative subtype among cases, stratified by race/ethnicity using logistic regression models</p

Supplementary Table 5 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between fibroids and hormone receptor status among only Non- Black / African American breast cancer cases</p

Supplementary Table 3 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between fibroids or endometriosis (+\- surgical status) and hormone receptor subtype among breast cancer cases using logistic regression models</p

Supplementary Table 1 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between fibroids diagnosed before age 35 (+/- uterine surgery) and breast cancer incidence, stratified by menopause status, using Cox proportional hazards models</p

Supplementary Table 4 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between fibroids and hormone receptor status among only Black / African American breast cancer cases</p

Supplementary Table 2 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between endometriosis diagnosed before age 35 (+/- uterine surgery) and breast cancer overall and stratified by menopause status using Cox proportional hazards model</p

Supplementary Table 7 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Association between endometriosis and triple negative subtype among cases stratified by race/ethnicity, using logistic regression models</p

Supplemental Figure 1 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Histogram demonstrating the distribution of the age of diagnosis of both endometriosis and fibroids in the Sister Study cohort.</p

Supplemental Figure 2 from Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes

Results from logistic regression model among breast cancer cases assessing the relationship between history of fibroids or endometriosis and breast cancer subtype (ER+ versus ER-, PR+ versus PR-, HER2+ versus HER2- and triple-negative vs. non-triple-negative), stratified by race. The referent group is no fibroids (or no endometriosis), regardless of surgical history. Age adjusted, partially adjusted, and fully adjusted models are included.</p

Supplemental Table 1 from Associations Between Serum Iron Biomarkers and Breast Cancer Tumor Size

Supplemental Table 1: Associations between iron biomarkers, tumor size, and metastatic status (excluding diagnoses within 6 months of baseline and over 4 years after baseline and women who took iron supplements 4+ days/week at baseline)</p